An Online Database Tool for Glycoproteomics of Lung Cancer Cell Lines for Biomarker Discovery and Anti-Cancer Screening of Natural Products

Angelica V. Ayos, Geoffrey A. Solano, Gilbert Luis F. Gapac, J. Reyes, J. Rabajante, Isagani D. Padolina, G. Completo, Ruel C. Nacario
{"title":"An Online Database Tool for Glycoproteomics of Lung Cancer Cell Lines for Biomarker Discovery and Anti-Cancer Screening of Natural Products","authors":"Angelica V. Ayos, Geoffrey A. Solano, Gilbert Luis F. Gapac, J. Reyes, J. Rabajante, Isagani D. Padolina, G. Completo, Ruel C. Nacario","doi":"10.1109/IISA56318.2022.9904333","DOIUrl":null,"url":null,"abstract":"Lung cancer is the most common among cancer-related deaths. In the Philippines, it is the top cause of cancer-related deaths among men and it is the third cause of cancer deaths among women. Plants have been used for cancer treatment throughout history. It is also known to be a major source of new drugs. Some of these promising natural products are still in various stages of clinical development. This study is part of the Philippine-California Advanced Research Institutes Institute for Health Improvement and Translation Medicine (PCARI-IHITM) 2017-2018 project, Glycoproteomics of Filipino Lung Cancer Cell Lines for Biomarker Discovery and Anti-Cancer Screening of Natural Products. Its goal is to identify biomarkers for different stages of lung cancers with the use of glycomic expression profiling, and to identify Philippine plant extracts that have potential preventive and therapeutic effects against lung cancer. It also aims to characterize, at molecule level, tumor tissues and blood samples from Filipino patients. The system developed in this study facilitates electronic record keeping system to allow secure and efficient storage, retrieval, visualization, and analysis of large data. This tool is expected to aid in biomarker discovery and anti-cancer screening of natural products for lung cancer drug development.","PeriodicalId":217519,"journal":{"name":"2022 13th International Conference on Information, Intelligence, Systems & Applications (IISA)","volume":"53 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2022 13th International Conference on Information, Intelligence, Systems & Applications (IISA)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/IISA56318.2022.9904333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Lung cancer is the most common among cancer-related deaths. In the Philippines, it is the top cause of cancer-related deaths among men and it is the third cause of cancer deaths among women. Plants have been used for cancer treatment throughout history. It is also known to be a major source of new drugs. Some of these promising natural products are still in various stages of clinical development. This study is part of the Philippine-California Advanced Research Institutes Institute for Health Improvement and Translation Medicine (PCARI-IHITM) 2017-2018 project, Glycoproteomics of Filipino Lung Cancer Cell Lines for Biomarker Discovery and Anti-Cancer Screening of Natural Products. Its goal is to identify biomarkers for different stages of lung cancers with the use of glycomic expression profiling, and to identify Philippine plant extracts that have potential preventive and therapeutic effects against lung cancer. It also aims to characterize, at molecule level, tumor tissues and blood samples from Filipino patients. The system developed in this study facilitates electronic record keeping system to allow secure and efficient storage, retrieval, visualization, and analysis of large data. This tool is expected to aid in biomarker discovery and anti-cancer screening of natural products for lung cancer drug development.
肺癌细胞系糖蛋白组学在线数据库工具,用于生物标志物的发现和天然产物的抗癌筛选
肺癌是癌症相关死亡中最常见的。在菲律宾,它是男性癌症相关死亡的首要原因,是女性癌症死亡的第三大原因。纵观历史,植物一直被用来治疗癌症。它也被认为是新药的主要来源。其中一些有前景的天然产品仍处于临床开发的不同阶段。该研究是菲律宾-加利福尼亚高级研究所健康改善和转化医学研究所(PCARI-IHITM) 2017-2018项目“菲律宾肺癌细胞系糖蛋白组学用于生物标志物发现和天然产物抗癌筛选”的一部分。其目标是利用糖糖表达谱鉴定不同阶段肺癌的生物标志物,并鉴定菲律宾植物提取物对肺癌具有潜在的预防和治疗作用。它还旨在在分子水平上表征菲律宾患者的肿瘤组织和血液样本。本研究开发的系统为电子档案保存系统提供了安全、高效的存储、检索、可视化和分析大数据的便利。该工具有望为肺癌药物开发的生物标志物发现和天然产物的抗癌筛选提供帮助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信